183 related articles for article (PubMed ID: 11704871)
1. CRBP suppresses breast cancer cell survival and anchorage-independent growth.
Kuppumbatti YS; Rexer B; Nakajo S; Nakaya K; Mira-y-Lopez R
Oncogene; 2001 Nov; 20(50):7413-9. PubMed ID: 11704871
[TBL] [Abstract][Full Text] [Related]
2. Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization.
Farias EF; Marzan C; Mira-y-Lopez R
Oncogene; 2005 Feb; 24(9):1598-606. PubMed ID: 15608670
[TBL] [Abstract][Full Text] [Related]
3. Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity.
Farias EF; Ong DE; Ghyselinck NB; Nakajo S; Kuppumbatti YS; Mira y Lopez R
J Natl Cancer Inst; 2005 Jan; 97(1):21-9. PubMed ID: 15632377
[TBL] [Abstract][Full Text] [Related]
4. ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth.
Hermanto U; Zong CS; Wang LH
Oncogene; 2001 Nov; 20(51):7551-62. PubMed ID: 11709727
[TBL] [Abstract][Full Text] [Related]
5. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
6. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
7. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
[TBL] [Abstract][Full Text] [Related]
8. Cellular retinol-binding protein expression and breast cancer.
Kuppumbatti YS; Bleiweiss IJ; Mandeli JP; Waxman S; Mira-Y-Lopez R
J Natl Cancer Inst; 2000 Mar; 92(6):475-80. PubMed ID: 10716965
[TBL] [Abstract][Full Text] [Related]
9. Physiological occurrence, biosynthesis and metabolism of retinoic acid: evidence for roles of cellular retinol-binding protein (CRBP) and cellular retinoic acid-binding protein (CRABP) in the pathway of retinoic acid homeostasis.
Napoli JL; Posch KP; Fiorella PD; Boerman MH
Biomed Pharmacother; 1991; 45(4-5):131-43. PubMed ID: 1932598
[TBL] [Abstract][Full Text] [Related]
10. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway.
Moore SM; Rintoul RC; Walker TR; Chilvers ER; Haslett C; Sethi T
Cancer Res; 1998 Nov; 58(22):5239-47. PubMed ID: 9823338
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer.
Arapshian A; Bertran S; Kuppumbatti YS; Nakajo S; Mira-y-Lopez R
Mol Cancer; 2004 Apr; 3():13. PubMed ID: 15113415
[TBL] [Abstract][Full Text] [Related]
14. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias.
Zhao S; Konopleva M; Cabreira-Hansen M; Xie Z; Hu W; Milella M; Estrov Z; Mills GB; Andreeff M
Leukemia; 2004 Feb; 18(2):267-75. PubMed ID: 14628071
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
[TBL] [Abstract][Full Text] [Related]
17. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis and metabolism of retinoic acid: roles of CRBP and CRABP in retinoic acid: roles of CRBP and CRABP in retinoic acid homeostasis.
Napoli JL
J Nutr; 1993 Feb; 123(2 Suppl):362-6. PubMed ID: 8381481
[TBL] [Abstract][Full Text] [Related]
19. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells.
Semba S; Itoh N; Ito M; Harada M; Yamakawa M
Clin Cancer Res; 2002 Jun; 8(6):1957-63. PubMed ID: 12060641
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid induces cellular retinol-binding protein in human skin in vivo.
Fisher GJ; Reddy AP; Datta SC; Kang S; Yi JY; Chambon P; Voorhees JJ
J Invest Dermatol; 1995 Jul; 105(1):80-6. PubMed ID: 7615982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
